Luteinizing hormone-releasing hormone (LHRH) agonists for treatment of advanced prostatic carcinoma

This publication has 11 references indexed in Scilit:

• Isolation and properties of the FSH and LH-releasing hormone
  Published by Elsevier ,2004
• Cardiovascular Side Effects of Diethylstilbestrol, Cyproterone Acetate, Medroxyprogesterone Acetate and Estramustine Phosphate Used for the Treatment of Advanced Prostatic Cancer: Results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762
  Journal of Urology, 1986
• Leuprolide versus Diethylstilbestrol for Metastatic Prostate Cancer
  New England Journal of Medicine, 1984
• Inhibition of prostate tumors by agonistic and antagonistic analogs of LH‐RH
  The Prostate, 1983
• Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men
  Fertility and Sterility, 1982
• Gonadotropin-Releasing Hormone Analogues for Prostate Cancer: Untoward Side Effects of High-Dose Regimens Acquire a Therapeutical Dimension
  European Urology, 1982
• LH‐RH Agonists and Antagonists
  International Journal of Gynecology & Obstetrics, 1980
• Treatment of Isolated Gonadotrop¡n Deficiency in Men with Synthetic LH-RH and a More Potent Analogue of LH-RH
  Neuroendocrinology, 1977
• Episodic Luteinizing Hormone Secretion in Man PULSE ANALYSIS, CLINICAL INTERPRETATION, PHYSIOLOGIC MECHANISMS
  Journal of Clinical Investigation, 1973
• Synthetic LH-Releasing Hormone (LH-RH) Administered to Normal Men by Different Routes*
  Journal of Clinical Endocrinology & Metabolism, 1973